- First long-term proof that a minimally invasive procedure eases swallowing in Allgrove syndrome
- Helps children and teens with rare genetic disorder who struggle to eat
- Available now in specialized centers—but not a cure, and lifelong care still needed
This procedure may finally give kids with Allgrove syndrome a chance to eat without pain.
Sixteen-year-old Li Wei hadn’t eaten a full meal in years. Even sipping water sometimes made him choke.
For kids like Li Wei, Allgrove syndrome isn’t just one problem—it’s three. They’re born without tears. Their bodies can’t handle stress. And over time, swallowing becomes harder and harder. Food feels like it gets stuck, no matter how slowly they eat.
This is achalasia—a condition where the valve at the bottom of the esophagus won’t relax. It’s like a door that won’t open, trapping food above. In Allgrove syndrome, it starts young, often by age 12. And until now, doctors weren’t sure what treatment worked best.
Allgrove syndrome is rare—fewer than 200 cases reported worldwide. But for families living with it, the daily struggle is real. Kids grow up needing cortisol pills, eye drops, and constant monitoring. Then, around puberty, swallowing turns painful.
Current treatments for achalasia include pills, balloon stretching, or surgery. But many don’t last. Some kids end up needing feeding tubes. Parents often feel helpless, watching their child starve despite eating.
There’s been no clear answer—until now.
The surprising shift
For years, doctors assumed achalasia in Allgrove syndrome was more severe than the common type. After all, it hits earlier and comes with other body-wide issues. So they often held back on aggressive treatments, fearing complications.
But what if that caution made things worse?
Here’s the twist: the new study found that kids with Allgrove syndrome actually reported fewer symptoms before treatment—yet still had the same physical blockage as adults with typical achalasia.
That means they may suffer in silence. And their pain might be underestimated.
What changed? A small incision, big results
Doctors tried a procedure called POEM—short for peroral endoscopic myotomy. No scalpels. No scars on the skin. Instead, a tiny camera goes down the throat.
Think of it like unlocking a jammed door from the inside. The surgeon cuts the tight muscle at the base of the esophagus—like snipping a rubber band that won’t let go.
The food can finally pass.
This doesn’t mean this treatment is available yet.
How it works—inside the body
Imagine your esophagus as a subway tunnel. Food is the train. The lower end is a gate that should open when the train arrives.
In achalasia, the gate stays shut. Nerves that tell it to open don’t work right. It doesn’t matter how fast or slow the train moves—the track ends in a wall.
POEM fixes the gate. It doesn’t cure the broken signal—but it removes the block.
For Allgrove patients, this is huge. Even though their nerves are damaged, the muscle itself can still be cut. And once it is, swallowing often returns.
Seven kids and teens with Allgrove syndrome got POEM at a top hospital in China. They were compared to 12 adults with typical achalasia who had the same procedure. All were followed for about six years—longer than any prior study.
Everyone had genetic testing. All had mutations in the AAAS gene—confirming the diagnosis.
Before POEM, Allgrove patients had lower symptom scores—only 5.3 on the Eckardt scale. The comparison group scored 7.6 (out of 9). But tests showed their esophagus was just as blocked.
After POEM? Scores dropped to 0.8 in Allgrove patients—near normal. Only one had mild trouble swallowing later. No serious complications.
That’s a dramatic improvement. And it lasted over five years.
That’s not the full story.
“This study flips the script,” said a gastroenterologist not involved in the research. “We used to think these kids were too fragile for POEM. Now we see they may benefit even more—because they’re younger and healthier overall.”
The key? Early diagnosis. Many kids go years without knowing they have Allgrove syndrome. They’re treated for acid reflux or anxiety—while the real problem grows.
If your child has trouble swallowing, especially with dry eyes or fatigue, ask about Allgrove syndrome. POEM is already used for achalasia in adults—and now in some children—at major medical centers.
It’s not a cure. Patients still need cortisol and eye drops. But for the first time, they may finally eat like other kids.
Talk to a specialist in motility disorders. Genetic testing is available. And if achalasia is confirmed, POEM could be an option—especially before damage becomes severe.
Only seven patients were studied. That’s small. But given how rare the disease is, it’s one of the largest groups ever followed.
All were treated at one hospital in China. Results may differ elsewhere. And long-term effects beyond ten years? Still unknown.
More centers need to track these patients. Researchers hope to build a global registry. With more data, POEM could become the go-to treatment for Allgrove-related achalasia—fast, safe, and lasting. But for now, awareness is the first step.
